To determine which revolutionary GLP-1 therapy or combination of therapies, including supporting peptides and metabolic protocols is right for your health plan, Schedule your consultation with Dr
When to Speak with Your Healthcare Professional Open communication with your diabetes care team is essential when managing diabetes during breastfeeding
In clinical trials, up to 50% of adults on Zepbound with PAP therapy experienced remission or mild, non-symptomatic OSA after one year
Since semaglutide encourages your pancreas to release insulin, the hormone that lowers blood sugar, it can leave you at risk of hypoglycemia
If youre considering Lexapro, be aware of the following
Heres how different groups responded to treatment: Race and Ethnicity : Clinical benefits were consistent across all racial and ethnic groups Type 2 Diabetes : Patients without diabetes achieved higher total body weight loss (16.9%) versus those with diabetes (9.9%) at 12 months Body Mass Index (BMI) : After two years of treatment, 52.4% of participants moved down at least one BMI category Results show that 12% of adults receiving semaglutide reached a healthy BMI of 25 kg/m or less, compared to only 1.2% in the placebo group